Paper Details

  1. Home
  2. Paper Details

Statins for multiple sclerosis.

Author: LuoHongye, LuoMan, WangJin, XiaoYousheng

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

There is no convincing evidence to support the use of either atorvastatin or simvastatin as an adjunctive therapy in multiple sclerosis (MS). Four trials comparing statins plus interferon beta-1a with interferon beta-1a alone did not show a statistically significant difference in reducing relapses, preventing disease progression, or developing new lesions on MRI.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the human central nervous system. Statins, prescribed as cholesterol lowering agents, have shown possible effects for treating MS in experimental and preliminary clinical studies. OBJECTIVES: To evaluate the efficacy an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175839/

データ提供：米国国立医学図書館（NLM）

Statins and Multiple Sclerosis: A Desert Mirage?

Multiple sclerosis (MS) is a complex and challenging neurological disorder. While statins are widely used to lower cholesterol, researchers have been investigating their potential for treating MS. This research delves into the effectiveness and safety of statins for treating MS.

The researchers conducted a meta-analysis of randomized controlled trials and found no convincing evidence to support the use of statins as an adjunctive therapy for MS. While the trials showed that statins were generally safe and well-tolerated, they did not demonstrate any statistically significant benefit in reducing relapses, preventing disease progression, or improving MRI outcomes.

The Ongoing Quest for Effective MS Treatments

The results of this study emphasize the need for further research to explore the potential role of statins in MS treatment. The search for effective treatments for MS continues, and researchers remain optimistic about finding new solutions for this debilitating disease.

A Reminder to Consult with Your Doctor

This research highlights the importance of relying on evidence-based information and consulting with your doctor before making any changes to your medication regimen. It's essential to discuss your specific circumstances and medical history with a healthcare professional to ensure you receive the best possible care.

Dr.Camel's Conclusion

This research is like a mirage in the desert of MS research. While it doesn't offer a definitive answer about the use of statins for MS, it underscores the importance of continued exploration and rigorous research to find effective treatments for this complex disease.

Date :
  1. Date Completed 2012-01-30
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22161428

DOI: Digital Object Identifier

PMC7175839

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.